Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis
Ovarian cancer (OC) is characterised by heterogeneity that complicates the prediction of patient survival and treatment outcomes. Here, we conducted analyses to predict the prognosis of patients from the Genomic Data Commons database and validated the predictions by fivefold cross-validation and by...
Main Authors: | Zhe Zhang, Zhiyao Wei, Luyang Zhao, Chenglei Gu, Yuanguang Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Journal of Obstetrics and Gynaecology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/01443615.2023.2171778 |
Similar Items
-
Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
by: Yinan Xiao, et al.
Published: (2022-05-01) -
Editorial: Multi-omics approaches in cancer research with applications in tumour prognosis, metastasis and biosensor based diagnosis of biomarkers
by: Mintu Pal, et al.
Published: (2023-03-01) -
Progress and Challenges of Immunotherapy Predictive Biomarkers for Triple Negative Breast Cancer in the Era of Single-Cell Multi-Omics
by: Jiangnan Yu, et al.
Published: (2023-05-01) -
Editorial: Multi-omics analysis of programmed cell death-mediated tumor microenvironment heterogeneity
by: Yanan Jiang, et al.
Published: (2024-03-01) -
Integrated Multi-Omic Analysis Reveals Immunosuppressive Phenotype Associated with Poor Outcomes in High-Grade Serous Ovarian Cancer
by: Russell Keathley, et al.
Published: (2023-07-01)